![]() |
市場調查報告書
商品編碼
2024636
眼科黏彈性器材市場規模:按產品、應用、最終用戶和地區分類,2026-2034 年Ophthalmic Viscoelastic Devices Market Size by Product, Application, End User, and Region 2026-2034 |
||||||
2025年,全球眼科黏彈性製劑(OVD)市場規模達29億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到39億美元,2026年至2034年的複合年成長率(CAGR)為3.21%。眼科手術數量的增加、積極的研發活動以及醫療產業的快速發展是推動市場成長的主要因素。
眼科黏彈劑(OVDs)是眼科手術中使用的醫療設備。它們廣泛應用於眼科及其他多種眼科手術,包括青光眼手術、角膜移植、玻璃體切除術和白內障手術。這些器械能夠保護眼球結構免受機械損傷,分離組織,創造空間,松解粘連,起到保濕作用,並作為輔助手術器械。 OVDs廣泛用於人工水晶體(IOL)植入術中維持眼內空間,穩定並加深前房,以及在前節手術中保護眼球結構。這些器械能夠產生前房壓力,分隔眼球,進而幫助患者獲得更好、更快、更安全的手術體驗。
全球眼科手術數量的不斷成長是市場成長的主要驅動力。黏彈劑(OVD)廣泛用於維持和固定手術空間、移位、穩定和保護組織。眼科醫療設施的普及和人們對眼科疾病認知的提高也促進了市場成長。此外,黏彈性自適應眼科黏彈劑的日益普及,以及其無需使用兩個注射器的雙相優勢,正在推動市場成長。另外,黏彈性OVD因其可避免術後併發症,在兒童白內障手術、虹膜鬆弛症候群、眼外傷和Fuchs角膜營養不良等複雜眼科手術中更受青睞,進一步推動了市場成長。此外,將聚集型和分散型OVD整合於同一單元的複合包裝的推出——可在手術中同時使用,具有成本效益高、可確保質量標準並減輕眼科醫生工作量等優點——正在加速市場成長。此外,老年人口的成長以及糖尿病和老齡化性眼科疾病率的上升也對市場成長產生了正面影響。其他促成市場前景光明的因素包括消費者購買力的增強、積極的研發活動、醫療行業的顯著擴張以及政府採取的各項措施,例如強制製造商推出新型眼科設備以遏制視力障礙的增加。
The global ophthalmic viscoelastic devices (OVD) market size reached USD 2.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.21% during 2026-2034. The increasing number of ophthalmic surgeries, extensive research and development (R&D) activities, and escalating growth in the healthcare industry represent some of the key factors driving the market.
Ophthalmic viscoelastic devices (OVD) are medical equipment used during eye surgeries. They are employed in ophthalmic and numerous eye surgeries, such as glaucoma, corneal transplant, and vitreoretinal and cataract surgery. These devices protect ocular structures from mechanical trauma, divide tissue, create space, resolve adhesions, act as a wetting agent, or as an instrument to facilitate the surgical procedure. OVDs are widely used to maintain space in the eye during intraocular lens (IOL) implantation, stabilize and deepen the anterior chamber, and protect ocular structures during anterior segment surgery. These devices assist in creating pressure within the anterior chamber, compartmentalizing inside the attention, and providing a faster and safer surgery with better recovery for the patients.
The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In addition to this, viscoadaptive OVD is also preferred in complex ocular surgeries, such as pediatric cataract surgery, patient with floppy iris syndrome, trauma, Fuchs dystrophy, and other cases to avoid post-surgical complications, which, in turn, is favoring the market growth. Apart from this, the introduction of a combination package of cohesive and dispersive OVD contained in a single unit, that is used simultaneously during procedures and is cost-effective, ensures quality standards and eases out ophthalmic surgeons' activities is providing an impetus to the market growth. Additionally, the rising geriatric population and the increasing prevalence of diabetes and age-related ocular disorders are positively influencing the market growth. Other factors, including the rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, and the implementation of various government initiatives to control the rising vision impairment by compelling producers to introduce new ophthalmic equipment, are creating a positive outlook for the market.
This report provides an analysis of the key trends in each segment of the global ophthalmic viscoelastic devices (OVD) market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on product, application, and end user.
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for ophthalmic viscoelastic devices (OVD). Some of the factors driving the North America ophthalmic viscoelastic devices (OVD) market included extensive research and development (R&D) activities, the rising geriatric population, and the increasing prevalence of diabetes and age-related ocular disorders.
The report has also provided a comprehensive analysis of the competitive landscape in the global ophthalmic viscoelastic devices (OVD) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Alcon Inc., Altacor Limited, Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc, Eyekon Medical Inc., Johnson & Johnson, RUMEX International Co., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.